IKZF1 Gene in Childhood B-cell Precursor Acute Lymphoblastic Leukemia: Interplay between Genetic Susceptibility and Somatic Abnormalities

Cancer Prev Res (Phila). 2017 Dec;10(12):738-744. doi: 10.1158/1940-6207.CAPR-17-0121. Epub 2017 Sep 25.

Abstract

SNPs in IKZF1 are associated with inherited susceptibility to B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Besides, somatic copy number abnormalities (CNA) in genes related to lymphopoiesis (e.g., IKZF1, CDKN2A/B, BTG1) impact patient's outcome. Therefore, this study aimed to investigate an association between germline susceptibility and CNAs in BCP-ALL. The IKZF1 SNPs (rs11978267 and rs4132601) were genotyped in 276 cases and 467 controls. Bone marrow samples were used to determine the presence of somatic abnormalities. The IKZF1 transcript levels were quantified and associated with the SNPs and CNAs. Categorical variables were compared by χ2 test. ORs were estimated with unconditional logistic regression with 95% confidence interval (CI). The variant allele of IKZF1 rs4132601 conferred increased risk of BCP-ALL (OR, 2.09; 95% CI, 1.16-3.74). Individuals with either rs11978267 or rs4132601 had an increased risk for harboring IKZF1 deletion (OR, 2.80; 95% CI, 1.25-6.23 and OR, 2.88; 95% CI, 1.24-6.69, respectively). Increased risks were observed for individuals harboring both IKZF1 and BTG1 deletions (OR, 4.90; 95% CI, 1.65-14.55, rs11978267 and OR, 5.80; 95% CI, 1.94-17.41, rs4132601). Germline genetic variation increases the risk for childhood ALL in general, but also acts as a susceptibility factor bound for risk of specific somatic alterations. These findings provide new insight into the development of childhood ALL regarding causal variants and the biological basis of the risk association, offering the opportunity for future tailored research. Cancer Prev Res; 10(12); 738-44. ©2017 AACR.

MeSH terms

  • Adolescent
  • Alleles
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cyclin-Dependent Kinase Inhibitor p18 / genetics
  • Female
  • Gene Deletion
  • Gene Dosage
  • Gene Expression Profiling
  • Genetic Predisposition to Disease*
  • Genetic Variation
  • Genotype
  • Germ-Line Mutation
  • Humans
  • Ikaros Transcription Factor / genetics*
  • Infant
  • Infant, Newborn
  • Leukemia, B-Cell / genetics
  • Male
  • Neoplasm Proteins / genetics
  • Odds Ratio
  • Polymorphism, Single Nucleotide*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Regression Analysis
  • Risk Factors
  • Treatment Outcome

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • Cyclin-Dependent Kinase Inhibitor p18
  • IKZF1 protein, human
  • Neoplasm Proteins
  • BTG1 protein, human
  • Ikaros Transcription Factor